Article info

Download PDFPDF
Injection frequency and anatomic outcomes 1 year following conversion to aflibercept in patients with neovascular age-related macular degeneration

Authors

  1. Correspondence to Dr Thomas Hwang, Casey Eye Institute, 3375 SW Terwilliger Blvd, Portland, OR 97239, USA; hwangt{at}ohsu.edu
View Full Text

Citation

Messenger WB, Campbell JP, Faridi A, et al
Injection frequency and anatomic outcomes 1 year following conversion to aflibercept in patients with neovascular age-related macular degeneration

Publication history

  • Received December 24, 2013
  • Revised March 13, 2014
  • Accepted April 4, 2014
  • First published May 2, 2014.
Online issue publication 
August 18, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.